1. matri Medication Assisted Treatment Reentry Initiative
Massachusetts Department of Correction

2. Purpose
To provide pre-release treatment and post-release referral for opioid- addicted and alcohol-addicted offenders at participating sites in the Department of Correction. The goal is to facilitate transition into an outpatient substance abuse treatment program which employs a multi-faceted approach to treatment including the use of the medication Naltrexone, counseling, and aftercare referral to community-based providers

3. Expanded SA Continuum Assessments Non-Residential Treatment Option
Move from public safety model to public health model
Non-Residential Treatment Option
2 additional programs at 9 facilities
Recover Support Navigators
Supported case management
Accountability after incarceration

4. Selected sites MCI Shirley Medium MCI Shirley Minimum MCI Concord
North Eastern Correctional Center
MCI Norfolk
Old Colony Correctional Center
MCI Framingham
South Middlesex Correctional Center
Boston Pre-Release Center
NOTE: Eligible offenders at other sites may be classified to a selected site.

5. Eligibility CRA or Gateway to Treatment graduate
Opioid and/or alcohol dependent
Interested in medication-assisted recovery
Remain engaged in recovery/treatment

6. Process
Responsible Timeline Initial Screening Spectrum 6 mo. Informational Session Spectrum 6 mo. Mental Health Screen MPCH 60 days Medical Screening HSU 60 days Weekly Groups Spectrum ongoing Urine Screen IPS 10 days Tolerance Trial HSU upon –UA Naltrexone Injection HSU 7 days Referral Discharge Planner 4-7 days

7. Outcomes Since September 2014 902 inmates screened 492 declined
257 deemed ineligible
41 completed (received injection and released)
6 scheduled for injection by end of July
56 inmates in screening process
50 inmates pending